Study of Busulfan and FLAG Conditioning Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation
Status:
Unknown status
Trial end date:
2020-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of Busulfan/FLAG
(fludarabine, cytarabine and granulocyte colony-stimulating factor) Conditioning Regimen in
Patients with Relapsed/refractory Acute Leukemia undergoing allogeneic peripheral blood stem
cell transplantation.
Phase:
Phase 4
Details
Lead Sponsor:
Chinese PLA General Hospital
Collaborators:
309th Hospital of Chinese People's Liberation Army Beijing Naval General Hospital Space Center Hospital, Peking University